FDA Reviewers Skeptical on TriClip for Tricuspid Regurgitation
Cardiology > > CHF-- Tricuspid valve repair work system is up for advisory committee examination on Tuesday
by Nicole Lou, Senior Staff Writer, MedPage Today February 12, 2024
FDA personnel questioned the proof for medical advantage with the TriClip G4 transcatheter edge-to-edge repair work (TEER) system for serious tricuspid regurgitation (TR) in files launched ahead of the firm's Circulatory System Devices Panel conference on Tuesday.
Producer Abbott has actually proposed a sign for enhancement of health status in clients with serious TR that is symptomatic regardless of ideal medical treatment and who are at inter...